Gene: Kras (KRAS proto-oncogene, GTPase) Rattus norvegicus
Analyze
Symbol:
Kras
Name:
KRAS proto-oncogene, GTPase
Description:
Exhibits GDP binding activity, GMP binding activity, and LRR domain binding activity; involved in several processes, including cytokine-mediated signaling pathway, female pregnancy, and response to corticosteroid; localizes to the membrane raft and mitochondrion; used to study bronchiolo-alveolar adenocarcinoma, endometrial adenocarcinoma, hepatocellular adenoma, hepatocellular carcinoma, and renal fibrosis; orthologous to human KRAS (KRAS proto-oncogene, GTPase); PARTICIPATES IN the extracellular signal-regulated Raf/Mek/Erk signaling pathway; altered extracellular signal-regulated Raf/Mek/Erk signaling pathway; endometrial cancer pathway; INTERACTS WITH (RS)-amphetamine; 17alpha-ethynylestradiol; 2,4-dinitrotoluene.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Also known as:
c-K-ras; c-K-ras2 protein; c-Ki-ras; c-Kirsten-ras proto-oncogene; GTPase KRas; K-Ras 2; ki-Ras; Kirsten rat sarcoma viral oncogene; Kirsten rat sarcoma viral oncogene homolog; Kirsten rat sarcoma viral oncogene homologue 2 (active); Kras2; p21; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
KRAS (KRAS proto-oncogene, GTPase) HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Kras (Kirsten rat sarcoma viral oncogene homolog) HGNC
Treefam, OrthoMCL, NCBI, OMA, HomoloGene, Inparanoid, Panther, PhylomeDB, OrthoDB, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
Kras (KRAS proto-oncogene, GTPase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
KRAS (KRAS proto-oncogene, GTPase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
KRAS (KRAS proto-oncogene, GTPase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Kras (KRAS proto-oncogene, GTPase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
KRAS (KRAS proto-oncogene, GTPase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
KRAS (KRAS proto-oncogene, GTPase)
Alliance
DIOPT (Ensembl Compara, HGNC, Hieranoid, InParanoid, OMA, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Mus musculus (house mouse):
Kras (Kirsten rat sarcoma viral oncogene homolog)
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Drosophila melanogaster (fruit fly):
Ras85D
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB)
Caenorhabditis elegans (roundworm):
let-60
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB)
Saccharomyces cerevisiae (baker's yeast):
RAS1
Alliance
DIOPT (Ensembl Compara, OrthoFinder, TreeFam)
Saccharomyces cerevisiae (baker's yeast):
RAS2
Alliance
DIOPT (Ensembl Compara, OrthoFinder, TreeFam)
Latest Assembly:
Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Rnor_6.0 4 179,482,562 - 179,515,483 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_5.0 4 243,667,912 - 243,696,325 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 4 182,869,242 - 182,895,106 (-) NCBI RGSC3.4 rn4 RGSC3.4 RGSC_v3.1 4 183,114,365 - 183,140,230 (-) NCBI Celera 4 166,708,846 - 166,734,692 (-) NCBI Celera Cytogenetic Map 4 q44 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Disease Annotations
RGD Manual Annotations
acute myeloid leukemia ISO RGD:1350859 1600469 OMIM:601626 RGD acute myeloid leukemia ISO RGD:1350859 11060151 RGD astrocytoma susceptibility ISO RGD:1550157 13702858 DNA:mutation:cds:p.G12D(mouse) RGD astrocytoma ISO RGD:1350859 1600476 sporadic pilocytic astrocytoma, OMIM:137800 RGD breast cancer ISO RGD:1350859 2314909 RGD Breast Neoplasms ISO RGD:1350859 1600466 human breast adenocarcinoma cell line, OMIM:114480 RGD bronchiolo-alveolar adenocarcinoma IMP 11075076 DNA:mutations:cds: RGD cardiofaciocutaneous syndrome ISO RGD:1350859 1600471 DNA:missense mutations:CDS:p.G60R, p.D153V (human) RGD cardiomyopathy no_association ISO RGD:1550157 11568677 RGD colorectal cancer disease_progression ISO RGD:1350859 14398748 DNA:missense mutations:cds:p.GLY12ASP,GLY12Val,GLY13ALA,GLY13ASP(human) RGD Colorectal Neoplasms ISO RGD:1350859 11060146 DNA:missense mutations: :p.G12C, p.G12D, p.G13D (human) RGD Colorectal Neoplasms ISO RGD:1550157 11568690 RGD dilated cardiomyopathy ISO RGD:1550157 1581757 RGD endometrial adenocarcinoma IAGP 1600499 DNA:point mutation:CDS:p.G12D, p.G12S, p.Q61H (rat) RGD endometrial hyperplasia ISO RGD:1350859 2314912 RGD Endometrial Neoplasms ISO RGD:1350859 4143515 RGD Endometrial Neoplasms ISO RGD:1350859 2314907 RGD Endometrioid Carcinomas ISO RGD:1350859 2314910 associated with Ovarian Neoplasms RGD Experimental Pancreatitis, Acute IEP 11062095 RGD Experimental Sarcoma IAGP 1598680 A to T transversion; more ... RGD fibrillary astrocytoma ISO RGD:1350859 13702872 mRNA:decreased expression:brain RGD glioblastoma multiforme treatment ISO RGD:1550157 13702861 RGD glioblastoma multiforme ISO RGD:1350859 13702872 mRNA:decreased expression:brain RGD grade III astrocytoma ISO RGD:1350859 13702872 mRNA:decreased expression:brain RGD hepatocellular adenoma induced IAGP 11568697 aflatoxin B1 induced:DNA:transversion,transition mutations:cds: RGD hepatocellular carcinoma ISO RGD:1350859 14398750 mRNA,protein:increased expression:liver RGD hepatocellular carcinoma induced IAGP 11568697 aflatoxin B1 induced:DNA:transversion,transition mutations:cds: RGD hypertension ISO RGD:1550157 1581757 RGD intellectual disability ISO RGD:1350859 1600477 Costello syndrome, OMIM:218040 RGD intrahepatic cholangiocarcinoma disease_progression ISO RGD:1350859 14398746 DNA:mutations:: RGD Kidney Neoplasms IDA 11570401 RGD lung adenocarcinoma ISO RGD:1350859 1600465 DNA:point mutation:CDS:p.G12C (human) RGD Lung Neoplasms ISO RGD:1550157 11568678 RGD lung non-small cell carcinoma ISO RGD:1350859 5133242 RGD malignant glioma severity ISO RGD:1550157 13702860 RGD malignant glioma severity ISO RGD:1350859 13702477 RGD Multiple Abnormalities ISO RGD:1350859 1600477 Costello syndrome, OMIM:218040 RGD multiple myeloma ISO RGD:1350859 1581756 RGD myeloid neoplasm ISO RGD:1550157 11060138 DNA:missense mutation: :p.G12D (mouse) RGD myeloid sarcoma ISO RGD:1350859 11060142 associated with Leukemia, Myeloid, Acute;DNA:missense mutation:exon:p.G12C (human) RGD Neoplasm Metastasis ISO RGD:1550157 11570402 associated with Fibrosarcoma;mRNA,protein:decreased expression:: RGD Neoplasm Metastasis treatment ISO RGD:1350859 11086960 associated with colorectal cancer;DNA:mutations: : RGD Neoplasm Metastasis treatment ISO RGD:1350859 14398751 associated with colorectal cancer; more ... RGD Neoplasm Metastasis disease_progression ISO RGD:1350859 14398745 associated with colorectal cancer;DNA:mutation: : RGD Noonan syndrome ISO RGD:1350859 1600472 Noonan syndrome type 3, OMIM:609942 RGD Noonan syndrome ISO RGD:1550157 11060134 DNA:missense mutation:exon:p.V14I (mouse) RGD Ovarian Neoplasms ISO RGD:1350859 2314911 RGD pancreatic cancer disease_progression ISO RGD:1350859 1581761 RGD pancreatic cancer ISO RGD:1350859 5490966 RGD pancreatic cancer ISO RGD:1350859 5490965 RGD pancreatic mucinous cystadenoma severity ISO RGD:1350859 14398747 DNA:mutations:cds: RGD precursor lymphoblastic lymphoma/leukemia ISO RGD:1350859 11060148 RGD precursor lymphoblastic lymphoma/leukemia disease_progression ISO RGD:1350859 11060149 RGD precursor T-lymphoblastic lymphoma/leukemia ISO RGD:1550157 11060136 DNA:missense mutation: :p.G12D (mouse) RGD prostate carcinoma in situ ISO RGD:1550157 2314913 RGD Prostatic Neoplasms ISO RGD:1550157 2314913 RGD renal cell carcinoma ISO RGD:1350859 2314914 mRNA:increased expression:kidney RGD renal fibrosis treatment IMP 11060152 associated with Ureteral Obstruction RGD seminoma ISO RGD:1350859 2314915 RGD stomach carcinoma ISO RGD:1350859 1600468 gastric cancer, OMIM:137215 RGD transitional cell carcinoma ISO RGD:1350859 2314836 mRNA:increased expression:urinary bladder RGD urinary bladder cancer ISO RGD:1350859 1600467 transitional cell bladder carcinoma, OMIM:109800 RGD Uterine Cervical Neoplasms ISO RGD:1350859 2314838 DNA:point mutation:exon (human) RGD
Imported Annotations - ClinVar
acute myeloid leukemia ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Acute myelogenous leukemia ClinVar PMID:12460918 more ... acute myeloid leukemia ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Leukemia, acute myelogenous ClinVar PMID:12460918 more ... acute myeloid leukemia ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Leukemia, acute myelogenous ClinVar PMID:12460918 more ... acute myeloid leukemia ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar PMID:12460918 more ... acute myeloid leukemia ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Acute myelocytic leukemia ClinVar PMID:15696205 more ... acute myeloid leukemia ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Leukemia, acute myeloid, UMLS MESH term: Acute Myelogenous Leukemia ClinVar PMID:8955068 adenoid cystic carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Adenoid cystic carcinoma ClinVar PMID:12460918 more ... angiosarcoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Angiosarcoma ClinVar PMID:24740626 more ... angiosarcoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Angiosarcoma ClinVar PMID:24740626 PMID:25157968 Aplasia Cutis Congenita with Epibulbar Dermoids ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Oculoectodermal syndrome ClinVar PMID:24740626 more ... arteriovenous malformations of the brain ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Arteriovenous malformations of the brain ClinVar PMID:15696205 more ... arteriovenous malformations of the brain ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Arteriovenous malformations of the brain ClinVar PMID:12460918 more ... autoimmune lymphoproliferative syndrome type 4 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IV ClinVar PMID:12460918 more ... autoimmune lymphoproliferative syndrome type 4 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: RAS-associated autoimmune leukoproliferative disorder ClinVar PMID:12460918 more ... autoimmune lymphoproliferative syndrome type 4 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: RAS-associated autoimmune leukoproliferative disorder ClinVar PMID:12460918 more ... B-Cell Chronic Lymphocytic Leukemia ISO RGD:1350859 8554872 ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia ClinVar PMID:12460918 more ... bladder urothelial carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Transitional cell bladder carcinoma ClinVar PMID:12460918 more ... breast adenocarcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Breast adenocarcinoma, somatic ClinVar PMID:12460918 more ... breast cancer ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Breast cancer, somatic ClinVar PMID:12460918 more ... Breast Cancer, Familial ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Familial cancer of breast ClinVar PMID:16474404 more ... cardiofaciocutaneous syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Cardio-facio-cutaneous syndrome ClinVar PMID:16474404 more ... cardiofaciocutaneous syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Cardiofaciocutaneous syndrome 1 ClinVar PMID:20186801 more ... cardiofaciocutaneous syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Cardio-facio-cutaneous syndrome ClinVar PMID:24033266 PMID:25741868 cardiofaciocutaneous syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Cardio-facio-cutaneous syndrome ClinVar PMID:24033266 more ... cardiofaciocutaneous syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Cardio-facio-cutaneous syndrome ClinVar PMID:24033266 cardiofaciocutaneous syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Cardio-facio-cutaneous syndrome ClinVar PMID:18922928 cardiofaciocutaneous syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Cardio-facio-cutaneous syndrome ClinVar cardiofaciocutaneous syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Cardio-facio-cutaneous syndrome ClinVar PMID:22980975 more ... cardiofaciocutaneous syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Cardio-facio-cutaneous syndrome ClinVar PMID:16474405 more ... Cardiofaciocutaneous Syndrome 2 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Cardiofaciocutaneous syndrome 2 ClinVar PMID:16474404 more ... Cardiofaciocutaneous Syndrome 2 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Cardiofaciocutaneous syndrome 2 ClinVar PMID:16474404 more ... Cardiofaciocutaneous Syndrome 2 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Cardiofaciocutaneous syndrome 2 ClinVar PMID:16773572 more ... Cardiofaciocutaneous Syndrome 2 ISO RGD:1350859 8554872 ClinVar Annotator: match by OMIM:615278 ClinVar PMID:21797849 PMID:23059812 Cardiofaciocutaneous Syndrome 2 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Cardiofaciocutaneous syndrome 2 ClinVar PMID:16474405 more ... Cardiofaciocutaneous Syndrome 2 ISO RGD:1350859 8554872 ClinVar Annotator: match by OMIM:615278 ClinVar PMID:17056636 PMID:18386799 chronic lymphocytic leukemia ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Chronic lymphocytic leukemia ClinVar PMID:12460918 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:16361624 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:12460918 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:16361624 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:12460918 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:12460918 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:12460918 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:12460918 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:12460918 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:12460918 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:12460918 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:12460918 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:16361624 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:12460918 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:12460918 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:12460918 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:11745231 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:12460918 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:16361624 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:25157968 Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:17384584 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:16361624 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:1553789 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:12460918 more ... Colorectal Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Colorectal Neoplasms ClinVar PMID:15696205 more ... craniopharyngioma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Craniopharyngioma ClinVar PMID:25741868 endometrial cancer ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Endometrial cancer ClinVar PMID:11745231 more ... endometrial carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Endometrial carcinoma ClinVar PMID:11745231 more ... endometrial carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Endometrial carcinoma ClinVar PMID:16474405 more ... epidermal nevus ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Nevus sebaceous ClinVar PMID:15696205 more ... epidermal nevus ISO RGD:1350859 8554872 ClinVar Annotator: match by term: NEVUS, KERATINOCYTIC, NONEPIDERMOLYTIC ClinVar PMID:12460918 more ... esophageal carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Esophageal carcinoma ClinVar PMID:16361624 more ... familial hypertrophic cardiomyopathy ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Cardiomyopathy, Hypertrophic, Familial ClinVar gastric adenocarcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Adenocarcinoma of stomach ClinVar PMID:12460918 more ... gastric adenocarcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Adenocarcinoma of stomach ClinVar PMID:16361624 more ... gastrointestinal stromal tumor ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Gastrointestinal stromal tumor ClinVar PMID:12460918 more ... genetic disease ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Inborn genetic diseases ClinVar PMID:16773572 more ... hepatocellular carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: LIVER CELL CARCINOMA ClinVar PMID:12460918 more ... hepatocellular carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: LIVER CELL CARCINOMA ClinVar PMID:16361624 more ... juvenile myelomonocytic leukemia ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Juvenile myelomonocytic leukemia ClinVar PMID:15696205 more ... juvenile myelomonocytic leukemia ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Juvenile myelomonocytic leukemia ClinVar PMID:12460918 more ... juvenile myelomonocytic leukemia ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Juvenile myelomonocytic leukemia ClinVar PMID:12460918 more ... juvenile myelomonocytic leukemia ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Juvenile myelomonocytic leukemia ClinVar PMID:12460918 more ... liver cancer ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Liver cancer ClinVar PMID:12460918 more ... liver cancer ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Liver cancer ClinVar PMID:16361624 more ... lung adenocarcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Adenocarcinoma of lung ClinVar PMID:12460918 more ... lung adenocarcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Adenocarcinoma of lung, somatic ClinVar PMID:12460918 more ... lung adenocarcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Adenocarcinoma of lung, somatic ClinVar PMID:11745231 more ... lung cancer ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Lung cancer ClinVar PMID:11745231 more ... lung cancer ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Lung cancer, somatic ClinVar PMID:12460918 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung carcinoma ClinVar PMID:16361624 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung carcinoma ClinVar PMID:12460918 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung cancer ClinVar PMID:12460918 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung cancer ClinVar PMID:12460918 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung cancer ClinVar PMID:12460918 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung cancer ClinVar PMID:12460918 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung cancer ClinVar PMID:12460918 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung cancer ClinVar PMID:12460918 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung cancer ClinVar PMID:12460918 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung cancer ClinVar PMID:12460918 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung cancer ClinVar PMID:12460918 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung cancer ClinVar PMID:12460918 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung cancer ClinVar PMID:12460918 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung cancer ClinVar PMID:12460918 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung cancer ClinVar PMID:11745231 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung cancer ClinVar PMID:16361624 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung cancer ClinVar PMID:12460918 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung carcinoma ClinVar PMID:15696205 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by synonym: Non-small cell lung cancer ClinVar lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung cancer ClinVar PMID:16474404 more ... lung non-small cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Non-small cell lung cancer ClinVar PMID:24033266 lung squamous cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Squamous cell carcinoma of lung ClinVar PMID:12460918 more ... lung squamous cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Squamous cell carcinoma of lung ClinVar PMID:12460918 more ... melanoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: MELANOMA, MALIGNANT, SOMATIC ClinVar PMID:16361624 more ... melanoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: MELANOMA, MALIGNANT, SOMATIC ClinVar PMID:12460918 more ... multiple myeloma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Multiple myeloma ClinVar PMID:12460918 more ... multiple myeloma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Multiple myeloma ClinVar PMID:16361624 more ... Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome ClinVar PMID:16474404 more ... Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome ClinVar PMID:16773572 more ... Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome ClinVar PMID:16474405 more ... Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome ClinVar PMID:16474405 more ... Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome ClinVar PMID:16474405 more ... Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome ClinVar PMID:12110640 more ... Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan's syndrome ClinVar PMID:16474404 more ... Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome ClinVar PMID:17056636 more ... Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome ClinVar PMID:24033266 PMID:25741868 Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome ClinVar PMID:24033266 more ... Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan's syndrome, UMLS OMIM term: NOONAN SYNDROME ClinVar PMID:12460918 more ... Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome ClinVar PMID:18922928 Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome ClinVar Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome ClinVar PMID:22980975 more ... Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan's syndrome, UMLS OMIM term: NOONAN SYNDROME ClinVar PMID:16773572 PMID:24033266 Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome ClinVar PMID:17056636 more ... Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome ClinVar PMID:22488932 PMID:24033266 Noonan syndrome ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome ClinVar PMID:24033266 Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome 3 ClinVar PMID:16474404 more ... Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome 3 ClinVar PMID:16474404 more ... Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome 3 ClinVar PMID:16474405 more ... Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome 3 ClinVar PMID:16474405 more ... Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome 3 ClinVar PMID:20186801 more ... Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome 3 ClinVar PMID:19396835 PMID:28492532 Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome 3 ClinVar PMID:16474405 more ... Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome 3 ClinVar PMID:17056636 more ... Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome 3 ClinVar PMID:25326635 more ... Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome 3 ClinVar PMID:12110640 more ... Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome 3 ClinVar PMID:16474404 more ... Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome 3 ClinVar PMID:17056636 more ... Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome 3 ClinVar PMID:25741868 Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Noonan syndrome 3 ClinVar PMID:12460918 more ... Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by OMIM:609942 ClinVar PMID:16773572 Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by OMIM:609942 ClinVar PMID:17056636 more ... Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by OMIM:609942 ClinVar PMID:16474404 more ... Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by OMIM:609942 ClinVar PMID:16773572 PMID:24033266 Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by OMIM:609942 ClinVar PMID:22488932 PMID:24033266 Noonan syndrome 3 ISO RGD:1350859 8554872 ClinVar Annotator: match by OMIM:609942 ClinVar PMID:17056636 ovarian cancer ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Ovarian cancer ClinVar PMID:12460918 more ... ovarian cancer ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Ovarian neoplasm ClinVar PMID:12460918 more ... Ovarian Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Ovarian neoplasm ClinVar PMID:12460918 more ... Ovarian Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Ovarian Neoplasms ClinVar PMID:12460918 more ... Ovarian Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Ovarian Neoplasms ClinVar PMID:12460918 more ... Ovarian Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Ovarian cancer ClinVar PMID:12460918 more ... Ovarian Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Ovarian Neoplasms ClinVar PMID:11745231 more ... Ovarian Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Ovarian Neoplasms ClinVar PMID:12460918 more ... Ovarian Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Ovarian Neoplasms ClinVar PMID:15696205 more ... pancreatic adenocarcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Pancreatic adenocarcinoma ClinVar PMID:12460918 more ... pancreatic cancer ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Pancreatic cancer ClinVar PMID:12460918 more ... pancreatic cancer ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Pancreatic cancer ClinVar PMID:15696205 more ... pancreatic carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: PANCREATIC CARCINOMA ClinVar PMID:15696205 more ... pancreatic carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: PANCREATIC CARCINOMA ClinVar PMID:12460918 more ... pilocytic astrocytoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Pilocytic astrocytoma ClinVar PMID:12460918 more ... plasmacytoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Plasmocytoma ClinVar PMID:12460918 more ... plasmacytoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Plasmocytoma ClinVar PMID:16361624 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:28492532 RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:16474404 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:16474404 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:16474405 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:16474405 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:19396835 PMID:28492532 RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:16474405 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:20147967 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:17056636 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: rasopathies ClinVar PMID:12460918 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:25326635 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:12110640 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:16474404 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:17056636 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:17056636 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:24033266 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:24033266 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:25741868 RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:24033266 PMID:25741868 RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:17056636 PMID:18386799 RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:15696205 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:17056636 RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:17056636 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:16474404 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:24033266 RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:17409930 more ... RASopathies ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Rasopathy ClinVar PMID:16474405 more ... Sebaceous Nevus of Jadassohn ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Nevus, Sebaceous of Jadassohn ClinVar PMID:12460918 more ... Sebaceous Nevus Syndrome and Hemimegalencephaly ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Sebaceous nevus syndrome and hemimegalencephaly ClinVar PMID:12460918 more ... stomach cancer ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Gastric cancer ClinVar PMID:12460918 more ... stomach cancer ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Gastric cancer ClinVar PMID:12460918 more ... thyroid medullary carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Medullary Thyroid Cancer ClinVar PMID:12460918 more ... Thyroid Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Neoplasm of the thyroid gland ClinVar PMID:12460918 more ... Thyroid Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Neoplasm of the thyroid gland ClinVar PMID:16361624 more ... Thyroid Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Neoplasm of the thyroid gland ClinVar PMID:12460918 more ... Thyroid Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Neoplasm of the thyroid gland ClinVar PMID:15696205 more ... Thyroid Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Neoplasm of the thyroid gland ClinVar PMID:12460918 more ... Thyroid Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Neoplasm of the thyroid gland ClinVar PMID:12460918 more ... Thyroid Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Neoplasm of the thyroid gland ClinVar PMID:17384584 more ... Thyroid Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Neoplasm of the thyroid gland ClinVar PMID:12460918 more ... Thyroid Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Neoplasm of the thyroid gland ClinVar PMID:12460918 more ... Thyroid Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Neoplasm of the thyroid gland ClinVar PMID:12460918 more ... Thyroid Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Neoplasm of the thyroid gland ClinVar PMID:11745231 more ... Thyroid Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Neoplasm of the thyroid gland ClinVar PMID:16361624 more ... Thyroid Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Neoplasm of the thyroid gland ClinVar PMID:12460918 more ... Thyroid Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Neoplasm of the thyroid gland ClinVar PMID:12460918 more ... Thyroid Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Neoplasm of the thyroid gland ClinVar PMID:12460918 more ... transitional cell carcinoma ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder ClinVar PMID:12460918 more ... urinary bladder cancer ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Bladder cancer ClinVar PMID:12460918 more ... urinary bladder cancer ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Bladder cancer, transitional cell, somatic ClinVar PMID:1553789 more ... Urinary Bladder Neoplasm ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Urinary Bladder Neoplasms ClinVar PMID:12460918 more ... Uterine Neoplasms ISO RGD:1350859 8554872 ClinVar Annotator: match by term: Malignant neoplasm of body of uterus ClinVar PMID:12460918 more ...
Imported Annotations - CTD
adenocarcinoma ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:11745231 more ... adenoma ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:8761429 more ... anemia ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:27725143 angiosarcoma ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:10930038 more ... Animal Disease Models ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:26390243 PMID:27588471 astrocytoma ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:23817572 Breast Neoplasms ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD Carcinogenesis ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:26595770 PMID:29247004 carcinoma ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:10545420 PMID:20565773 cardiofaciocutaneous syndrome ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:17703371 Cecal Neoplasms ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:14688030 Cell Transformation, Neoplastic ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:27510461 cholangiocarcinoma ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:8968066 PMID:22561520 Colonic Neoplasms ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:10813127 more ... Colorectal Neoplasms ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:20565773 more ... Costello syndrome ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:17468812 PMID:17703371 disease of cellular proliferation ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:10673434 PMID:26595770 Disease Progression ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:30654191 endometriosis ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:23284138 Experimental Liver Neoplasms ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:8603461 Experimental Neoplasms ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:9205081 more ... follicular thyroid carcinoma ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:27440272 Gallbladder Neoplasms ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:24997986 hepatocellular carcinoma ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:11286481 PMID:11563603 juvenile myelomonocytic leukemia ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:26457647 juvenile rheumatoid arthritis ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:19565504 Leukocytosis ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:27725143 liver benign neoplasm ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:10629081 PMID:12211074 Lung Neoplasms ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:7614698 more ... lung non-small cell carcinoma ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:21336183 more ... lymphoma ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:9205081 Mouth Neoplasms ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:19435901 myelodysplastic syndrome ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:27992414 Neoplasm Metastasis ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:8635384 neuroblastoma ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:26121086 Noonan syndrome ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:17468812 more ... Ovarian Neoplasms ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:21372221 pancreatic cancer ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:14520703 more ... pancreatic ductal carcinoma ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:25347530 PMID:30654191 Parasitic Liver Diseases ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:22561520 penile neoplasm ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:18355852 Prostatic Neoplasms ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:29610475 Recurrence ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:26121086 Sebaceous Nevus of Jadassohn ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:22683711 Splenomegaly ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:27725143 squamous cell carcinoma ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:19435901 PMID:25125259 Stomach Neoplasms ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:10874023 PMID:11397402 Thyroid Neoplasms ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:3078959 Triple Negative Breast Neoplasms ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:30654191 urinary bladder cancer ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:29644616 Uterine Neoplasms ISO RGD:1350859 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:17325976 Imported Annotations - MGI
intrahepatic cholangiocarcinoma ISS RGD:1550157 13592920 MouseDO lung cancer ISS RGD:1550157 13592920 OMIM:211980 | OMIM:608935 | OMIM:612571 | OMIM:612593 | OMIM:614210 MouseDO pancreatic carcinoma ISS RGD:1550157 13592920 OMIM:260350 MouseDO prostate cancer ISS RGD:1550157 13592920 OMIM:176807 | OMIM:300147 | OMIM:300704 | OMIM:601518 | OMIM:602759 | OMIM:608656 | OMIM:608658 | OMIM:609299 | OMIM:609558 | OMIM:610321 | OMIM:610997 | OMIM:611100 | OMIM:611868 | OMIM:611928 | OMIM:611955 | OMIM:611958 | OMIM:611959 MouseDO stomach cancer ISS RGD:1350859 13592920 OMIM:137215 | OMIM:613659 MouseDO Imported Annotations - OMIM
acute myeloid leukemia ISO RGD:1350859 7240710 OMIM arteriovenous malformations of the brain ISO RGD:1350859 7240710 OMIM autoimmune lymphoproliferative syndrome type 4 ISO RGD:1350859 7240710 OMIM breast cancer ISO RGD:1350859 7240710 OMIM Cardiofaciocutaneous Syndrome 2 ISO RGD:1350859 7240710 OMIM Lung Neoplasms ISO RGD:1350859 7240710 OMIM Noonan syndrome 3 ISO RGD:1350859 7240710 OMIM pancreatic cancer ISO RGD:1350859 7240710 OMIM Sebaceous Nevus of Jadassohn ISO RGD:1350859 7240710 OMIM Stomach Neoplasms ISO RGD:1350859 7240710 OMIM urinary bladder cancer ISO RGD:1350859 7240710 OMIM
(1R)-1,4-anhydro-1-(4-carbamoyl-1,3-thiazol-2-yl)-D-ribitol multiple interactions ISO RGD:1350859 6480464 Guanosine inhibits the reaction [tiazofurin results in decreased expression of KRAS] CTD PMID:9381980 (1R)-1,4-anhydro-1-(4-carbamoyl-1,3-thiazol-2-yl)-D-ribitol decreases expression ISO RGD:1350859 6480464 tiazofurin results in decreased expression of KRAS CTD PMID:9381980 (RS)-amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of KRAS mRNA CTD PMID:30779732 (trichloromethyl)benzene increases mutagenesis ISO RGD:1550157 6480464 benzotrichloride results in increased mutagenesis of KRAS gene CTD PMID:8508514 1,1-dichloroethene increases expression ISO RGD:1550157 6480464 vinylidene chloride results in increased expression of KRAS mRNA CTD PMID:26682919 1-nitropyrene increases mutagenesis ISO RGD:1550157 6480464 1-nitropyrene results in increased mutagenesis of KRAS gene CTD PMID:10396879 more ... 1-nitropyrene multiple interactions ISO RGD:1550157 6480464 [1-nitropyrene co-treated with KC 400] results in increased mutagenesis of KRAS gene; more ... CTD PMID:10396879 more ... 17alpha-ethynylestradiol multiple interactions ISO RGD:1550157 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KRAS mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of KRAS mRNA CTD PMID:29097150 17beta-estradiol decreases expression ISO RGD:1350859 6480464 Estradiol results in decreased expression of KRAS mRNA CTD PMID:16474171 17beta-estradiol increases expression ISO RGD:1350859 6480464 Estradiol results in increased expression of KRAS mRNA CTD PMID:23094148 2,2-Bis(bromomethyl)propane-1,3-diol increases mutagenesis ISO RGD:1550157 6480464 2,2-bis(bromomethyl)-1,3-propanediol results in increased mutagenesis of KRAS gene CTD PMID:14713543 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1350859 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of KRAS mRNA] CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550157 6480464 Tetrachlorodibenzodioxin affects the expression of KRAS mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1350859 6480464 Tetrachlorodibenzodioxin results in increased expression of KRAS mRNA CTD PMID:11007951 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1350859 6480464 Tetrachlorodibenzodioxin affects the expression of KRAS mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1550157 6480464 Tetrachlorodibenzodioxin results in decreased expression of KRAS mRNA CTD PMID:14708085 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1550157 6480464 Tetrachlorodibenzodioxin results in increased expression of KRAS mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550157 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KRAS mRNA; more ... CTD PMID:11884234 more ... 2,4-dinitrotoluene affects expression EXP 6480464 2,4-dinitrotoluene affects the expression of KRAS mRNA CTD PMID:21346803 2,6-di-tert-butyl-4-methylphenol increases mutagenesis ISO RGD:1550157 6480464 Butylated Hydroxytoluene results in increased mutagenesis of KRAS gene CTD PMID:20101149 2-trans,6-trans-farnesyl diphosphate multiple interactions EXP 6480464 [FNTA protein binds to FNTB protein] binds to [farnesyl pyrophosphate analog co-treated with KRAS protein] CTD PMID:10673434 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine increases mutagenesis EXP 6480464 2-amino-3-methylimidazo(4,5-f)quinoline results in increased mutagenesis of KRAS gene CTD PMID:8844820 3-methylcholanthrene multiple interactions ISO RGD:1550157 6480464 Methylcholanthrene promotes the reaction [GATA6 protein binds to KRAS exon]; more ... CTD PMID:16271038 3-methylcholanthrene increases mutagenesis ISO RGD:1550157 6480464 Methylcholanthrene results in increased mutagenesis of KRAS gene CTD PMID:11195466 PMID:20101149 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases mutagenesis EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased mutagenesis of KRAS gene CTD PMID:18271921 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO RGD:1550157 6480464 [Lipopolysaccharides co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased mutagenesis of KRAS gene CTD PMID:21868532 4-vinylcyclohexene dioxide affects expression ISO RGD:1550157 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of KRAS mRNA CTD PMID:20829426 5-fluorouracil decreases expression ISO RGD:1350859 6480464 Fluorouracil results in decreased expression of KRAS protein CTD PMID:15585135 PMID:16803524 5-Methylchrysene increases mutagenesis ISO RGD:1550157 6480464 5-methylchrysene results in increased mutagenesis of KRAS gene CTD PMID:8571376 PMID:9659573 acrolein decreases expression ISO RGD:1350859 6480464 Acrolein results in decreased expression of KRAS protein CTD PMID:24812010 actinomycin D multiple interactions ISO RGD:1350859 6480464 Dactinomycin inhibits the reaction [[KRAS protein mutant form affects the susceptibility to vemurafenib] which results in increased expression of TNFRSF10B mRNA] CTD PMID:27222248 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of KRAS mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1350859 6480464 Antirheumatic Agents results in decreased expression of KRAS mRNA CTD PMID:24449571 aristolochic acid increases mutagenesis EXP 6480464 aristolochic acid I results in increased mutagenesis of KRAS gene CTD PMID:21642617 Aroclor 1254 decreases expression ISO RGD:1550157 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of KRAS mRNA; more ... CTD PMID:23650126 Aroclor 1254 affects localization ISO RGD:1550157 6480464 Chlorodiphenyl (54% Chlorine) affects the localization of KRAS protein CTD PMID:9525281 arsane multiple interactions ISO RGD:1350859 6480464 KRAS affects the reaction [Arsenic results in increased phosphorylation of MAPK1 protein]; more ... CTD PMID:25273566 arsane affects response to substance ISO RGD:1350859 6480464 KRAS affects the susceptibility to Arsenic CTD PMID:25273566 arsenic atom multiple interactions ISO RGD:1350859 6480464 KRAS affects the reaction [Arsenic results in increased phosphorylation of MAPK1 protein]; more ... CTD PMID:25273566 arsenic atom affects response to substance ISO RGD:1350859 6480464 KRAS affects the susceptibility to Arsenic CTD PMID:25273566 arsenic(3+) affects response to substance ISO RGD:1350859 6480464 KRAS affects the susceptibility to Arsenic CTD PMID:25273566 arsenic(3+) multiple interactions ISO RGD:1350859 6480464 KRAS affects the reaction [Arsenic results in increased phosphorylation of MAPK1 protein]; more ... CTD PMID:25273566 arsenite(3-) multiple interactions ISO RGD:1350859 6480464 decitabine inhibits the reaction [arsenite results in increased expression of KRAS protein]; more ... CTD PMID:24704393 arsenite(3-) increases expression ISO RGD:1350859 6480464 arsenite results in increased expression of KRAS protein CTD PMID:24704393 asbestos increases mutagenesis ISO RGD:1350859 6480464 Asbestos results in increased mutagenesis of KRAS gene CTD PMID:12725029 Benz[j]aceanthrylene increases mutagenesis ISO RGD:1550157 6480464 benz(j)aceanthrylene results in increased mutagenesis of KRAS gene CTD PMID:9659573 benzene increases response to substance ISO RGD:1550157 6480464 KRAS gene polymorphism results in increased susceptibility to Benzene CTD PMID:12807761 benzo[a]pyrene increases expression ISO RGD:1550157 6480464 Benzo(a)pyrene results in increased expression of KRAS mRNA CTD PMID:22228805 benzo[a]pyrene increases mutagenesis ISO RGD:1550157 6480464 Benzo(a)pyrene results in increased mutagenesis of KRAS gene CTD PMID:19658153 more ... benzo[a]pyrene diol epoxide I increases expression ISO RGD:1350859 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of KRAS mRNA; more ... CTD PMID:18567617 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1350859 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KRAS mRNA CTD PMID:19150397 PMID:20018196 benzo[b]fluoranthene increases mutagenesis ISO RGD:1550157 6480464 benzo(b)fluoranthene results in increased mutagenesis of KRAS gene CTD PMID:8571376 PMID:9659573 bisphenol A decreases expression ISO RGD:1350859 6480464 bisphenol A results in decreased expression of KRAS mRNA CTD PMID:16474171 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of KRAS gene CTD PMID:28505145 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of KRAS mRNA CTD PMID:29097150 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of KRAS mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1550157 6480464 bisphenol A results in increased expression of KRAS mRNA CTD PMID:26063408 bisphenol A increases mutagenesis ISO RGD:1350859 6480464 bisphenol A results in increased mutagenesis of KRAS gene CTD PMID:11342245 bleomycin A2 multiple interactions ISO RGD:1550157 6480464 [Bleomycin co-treated with 1-nitropyrene] results in increased mutagenesis of KRAS gene CTD PMID:12616606 buta-1,3-diene increases mutagenesis ISO RGD:1550157 6480464 1,3-butadiene results in increased mutagenesis of KRAS gene CTD PMID:11397402 cadmium atom increases expression ISO RGD:1350859 6480464 Cadmium results in increased expression of KRAS mRNA; more ... CTD PMID:20049202 cadmium atom decreases expression ISO RGD:1350859 6480464 Cadmium results in decreased expression of KRAS mRNA CTD PMID:21120746 cadmium dichloride increases expression ISO RGD:1350859 6480464 Cadmium Chloride results in increased expression of KRAS mRNA; more ... CTD PMID:23811327 more ... cadmium dichloride multiple interactions ISO RGD:1350859 6480464 KRAS protein inhibits the reaction [Cadmium Chloride results in decreased expression of MIR155 mRNA]; more ... CTD PMID:27510461 carbamazepine affects expression ISO RGD:1350859 6480464 Carbamazepine affects the expression of KRAS mRNA CTD PMID:24752500 carbon nanotube increases mutagenesis ISO RGD:1550157 6480464 Nanotubes, Carbon results in increased mutagenesis of KRAS gene CTD PMID:24213921 ceruletide multiple interactions ISO RGD:1550157 6480464 (+)-JQ1 compound inhibits the reaction [[KRAS protein mutant form co-treated with Ceruletide] results in increased expression of BRD4 protein]; more ... CTD PMID:26390243 chloroethene multiple interactions ISO RGD:1350859 6480464 CYP2E1 gene polymorphism promotes the reaction [Vinyl Chloride affects the mutagenesis of KRAS gene]; more ... CTD PMID:12705718 more ... chloroethene increases mutagenesis ISO RGD:1350859 6480464 Vinyl Chloride results in increased mutagenesis of KRAS gene CTD PMID:10629081 more ... chloroethene increases response to substance ISO RGD:1550157 6480464 KRAS gene polymorphism results in increased susceptibility to Vinyl Chloride CTD PMID:12807761 chloroprene increases mutagenesis ISO RGD:1550157 6480464 Chloroprene results in increased mutagenesis of KRAS gene CTD PMID:10223196 PMID:11397402 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of KRAS mRNA CTD PMID:18668222 cisplatin multiple interactions ISO RGD:1350859 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of KRAS mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1350859 6480464 Cisplatin results in decreased expression of KRAS mRNA CTD PMID:27392435 clofibrate increases expression ISO RGD:1550157 6480464 Clofibrate results in increased expression of KRAS mRNA CTD PMID:23811191 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of KRAS mRNA; more ... CTD PMID:17418555 PMID:22465980 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of KRAS mRNA; more ... CTD PMID:17418555 PMID:22465980 copper(2+) increases expression EXP 6480464 Copper deficiency results in increased expression of KRAS mRNA; more ... CTD PMID:17418555 PMID:22465980 coumestrol decreases expression ISO RGD:1350859 6480464 Coumestrol results in decreased expression of KRAS mRNA CTD PMID:19167446 crizotinib decreases response to substance ISO RGD:1350859 6480464 KRAS protein mutant form results in decreased susceptibility to crizotinib CTD PMID:22235099 cumene multiple interactions ISO RGD:1550157 6480464 [cumene co-treated with KRAS gene mutant form] results in decreased expression of CCN1 mRNA; more ... CTD PMID:18648096 curcumin decreases expression ISO RGD:1350859 6480464 Curcumin analog results in decreased expression of KRAS mRNA; more ... CTD PMID:17041101 curcumin multiple interactions ISO RGD:1550157 6480464 Curcumin affects the reaction [KRAS protein affects the localization of TRP53 protein]; more ... CTD PMID:21519798 cycloheximide multiple interactions ISO RGD:1350859 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of KRAS mRNA] CTD PMID:11007951 Cyclopenta[cd]pyrene increases mutagenesis ISO RGD:1550157 6480464 cyclopenta(c,d)pyrene results in increased mutagenesis of KRAS gene CTD PMID:9659573 dabrafenib multiple interactions ISO RGD:1350859 6480464 [KRAS protein affects the susceptibility to dabrafenib] which affects the expression of TNFRSF10B protein; more ... CTD PMID:27222248 dabrafenib affects response to substance ISO RGD:1350859 6480464 KRAS protein affects the susceptibility to dabrafenib CTD PMID:27222248 dibenzo[a,l]pyrene increases mutagenesis ISO RGD:1550157 6480464 dibenzo(a,l)pyrene results in increased mutagenesis of KRAS gene CTD PMID:9659573 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of KRAS mRNA CTD PMID:18636392 diclofenac affects expression ISO RGD:1350859 6480464 Diclofenac affects the expression of KRAS mRNA CTD PMID:24752500 dorsomorphin multiple interactions ISO RGD:1350859 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KRAS mRNA; more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1350859 6480464 Doxorubicin results in decreased expression of KRAS mRNA CTD PMID:29803840 erlotinib hydrochloride increases response to substance ISO RGD:1350859 6480464 KRAS protein results in increased susceptibility to Erlotinib Hydrochloride CTD PMID:20705357 ethanol affects splicing ISO RGD:1550157 6480464 Ethanol affects the splicing of KRAS mRNA CTD PMID:30319688 farnesyl diphosphate multiple interactions EXP 6480464 [FNTA protein binds to FNTB protein] binds to [farnesyl pyrophosphate analog co-treated with KRAS protein] CTD PMID:10673434 flutamide increases expression EXP 6480464 Flutamide results in increased expression of KRAS mRNA CTD PMID:24136188 folic acid increases expression ISO RGD:1550157 6480464 Folic Acid results in increased expression of KRAS mRNA CTD PMID:2566606 GDP multiple interactions ISO RGD:1350859 6480464 KRAS protein mutant form inhibits the reaction [SOS1 protein inhibits the reaction [Guanosine Diphosphate binds to KRAS protein]]; more ... CTD PMID:28154176 GDP affects binding ISO RGD:1350859 6480464 Guanosine Diphosphate binds to KRAS protein; more ... CTD PMID:28154176 gefitinib affects response to substance ISO RGD:1350859 6480464 KRAS protein mutant form affects the susceptibility to gefitinib CTD PMID:17270025 gefitinib decreases response to substance ISO RGD:1350859 6480464 KRAS protein results in decreased susceptibility to gefitinib CTD PMID:28739874 gefitinib multiple interactions ISO RGD:1350859 6480464 KRAS protein affects the reaction [EGFR protein affects the susceptibility to gefitinib] CTD PMID:28739874 genistein decreases expression ISO RGD:1350859 6480464 Genistein results in decreased expression of KRAS mRNA CTD PMID:15256057 PMID:16474171 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of KRAS mRNA CTD PMID:22061828 GTP multiple interactions ISO RGD:1350859 6480464 KRAS protein mutant form inhibits the reaction [RASA1 protein promotes the reaction [KRAS protein results in increased hydrolysis of Guanosine Triphosphate]]; more ... CTD PMID:28154176 GTP affects binding ISO RGD:1350859 6480464 Guanosine Triphosphate binds to KRAS protein; more ... CTD PMID:28154176 GTP increases hydrolysis ISO RGD:1350859 6480464 KRAS protein mutant form results in increased hydrolysis of Guanosine Triphosphate; more ... CTD PMID:28154176 guanosine multiple interactions ISO RGD:1350859 6480464 Guanosine inhibits the reaction [tiazofurin results in decreased expression of KRAS] CTD PMID:9381980 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of KRAS mRNA CTD PMID:15860345 hydroquinone multiple interactions ISO RGD:1350859 6480464 [PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of KRAS protein CTD PMID:28444915 hydroxyurea decreases expression ISO RGD:1550157 6480464 Hydroxyurea results in decreased expression of KRAS mRNA CTD PMID:12929121 ionomycin multiple interactions ISO RGD:1350859 6480464 Methohexital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of KRAS protein]; more ... CTD PMID:15263067 isoprenaline increases expression ISO RGD:1550157 6480464 Isoproterenol results in increased expression of KRAS mRNA CTD PMID:21335049 isoprene increases mutagenesis ISO RGD:1550157 6480464 isoprene results in increased mutagenesis of KRAS gene CTD PMID:11397402 PMID:9111215 isotretinoin decreases expression ISO RGD:1350859 6480464 Isotretinoin results in decreased expression of KRAS mRNA CTD PMID:20436886 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of KRAS mRNA CTD PMID:19700661 lapatinib multiple interactions ISO RGD:1350859 6480464 KRAS protein affects the reaction [EGFR protein affects the susceptibility to lapatinib] CTD PMID:28739874 lapatinib decreases response to substance ISO RGD:1350859 6480464 KRAS protein results in decreased susceptibility to lapatinib CTD PMID:28739874 lead diacetate decreases expression ISO RGD:1550157 6480464 lead acetate results in decreased expression of KRAS mRNA CTD PMID:21829687 lead diacetate multiple interactions ISO RGD:1350859 6480464 [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of KRAS mRNA CTD PMID:22839698 lead diacetate increases expression ISO RGD:1550157 6480464 lead acetate results in increased expression of KRAS mRNA CTD PMID:25270620 lead(0) increases expression ISO RGD:1550157 6480464 Lead results in increased expression of KRAS protein CTD PMID:19727529 lead(2+) increases expression ISO RGD:1550157 6480464 Lead results in increased expression of KRAS protein CTD PMID:19727529 lipopolysaccharide multiple interactions ISO RGD:1550157 6480464 [Lipopolysaccharides co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased mutagenesis of KRAS gene CTD PMID:21868532 lovastatin decreases prenylation ISO RGD:1350859 6480464 Lovastatin results in decreased prenylation of KRAS protein CTD PMID:16156861 lovastatin increases expression ISO RGD:1550157 6480464 Lovastatin results in increased expression of KRAS protein CTD PMID:12907238 lovastatin affects localization ISO RGD:1550157 6480464 Lovastatin affects the localization of KRAS protein CTD PMID:12106604 lovastatin increases activity ISO RGD:1550157 6480464 Lovastatin results in increased activity of KRAS protein CTD PMID:17005160 Manumycin A multiple interactions ISO RGD:1350859 6480464 Acetylcysteine inhibits the reaction [manumycin results in decreased activity of KRAS protein] CTD PMID:19409983 Manumycin A decreases activity ISO RGD:1350859 6480464 manumycin results in decreased activity of KRAS protein CTD PMID:19409983 MeIQx increases mutagenesis EXP 6480464 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased mutagenesis of KRAS gene CTD PMID:18271921 mercury dibromide decreases expression ISO RGD:1350859 6480464 mercuric bromide results in decreased expression of KRAS mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1350859 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KRAS mRNA CTD PMID:27188386 metformin multiple interactions ISO RGD:1350859 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of KRAS mRNA CTD PMID:29309887 methohexital multiple interactions ISO RGD:1350859 6480464 Methohexital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of KRAS protein] CTD PMID:15263067 methotrexate increases response to substance ISO RGD:1350859 6480464 KRAS gene mutant form results in increased susceptibility to Methotrexate CTD PMID:24688052 methotrexate decreases expression ISO RGD:1350859 6480464 Methotrexate results in decreased expression of KRAS mRNA; more ... CTD PMID:24688052 N,N-bis(2-hydroxypropyl)nitrosamine increases mutagenesis EXP 6480464 diisopropanolnitrosamine results in increased mutagenesis of KRAS gene CTD PMID:18271921 N-acetyl-L-cysteine multiple interactions ISO RGD:1350859 6480464 Acetylcysteine inhibits the reaction [manumycin results in decreased activity of KRAS protein] CTD PMID:19409983 N-ethyl-N-nitrosourea multiple interactions ISO RGD:1550157 6480464 Ethylnitrosourea promotes the reaction [GATA6 protein binds to KRAS exon]; more ... CTD PMID:16271038 N-ethyl-N-nitrosourea increases mutagenesis ISO RGD:1550157 6480464 Ethylnitrosourea results in increased mutagenesis of KRAS gene CTD PMID:15790496 N-methyl-N-nitrosourea decreases response to substance EXP 6480464 KRAS protein results in decreased susceptibility to Methylnitrosourea CTD PMID:11973638 N-methyl-N-nitrosourea increases mutagenesis ISO RGD:1550157 6480464 Methylnitrosourea results in increased mutagenesis of KRAS gene CTD PMID:12483526 PMID:18062963 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of KRAS mRNA CTD PMID:7910516 N-nitrosodiethylamine increases expression ISO RGD:1550157 6480464 Diethylnitrosamine results in increased expression of KRAS mRNA CTD PMID:26464624 N-nitrosodimethylamine affects localization ISO RGD:1550157 6480464 Dimethylnitrosamine affects the localization of KRAS protein CTD PMID:11884234 N-nitrosodimethylamine multiple interactions ISO RGD:1550157 6480464 Dimethylnitrosamine results in decreased expression of and affects the localization of KRAS protein; more ... CTD PMID:11884234 PMID:19555203 nicotinic acid affects localization ISO RGD:1550157 6480464 Niacin affects the localization of KRAS protein CTD PMID:12106604 oxirane increases mutagenesis ISO RGD:1550157 6480464 Ethylene Oxide results in increased mutagenesis of KRAS gene CTD PMID:24029818 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of KRAS mRNA CTD PMID:18636392 ozone increases expression EXP 6480464 Ozone results in increased expression of KRAS mRNA CTD PMID:16330353 p-chloromercuribenzoic acid decreases expression ISO RGD:1350859 6480464 p-Chloromercuribenzoic Acid results in decreased expression of KRAS mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1350859 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KRAS mRNA CTD PMID:27188386 paclitaxel multiple interactions ISO RGD:1350859 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of KRAS mRNA CTD PMID:29309887 paracetamol affects expression ISO RGD:1550157 6480464 Acetaminophen affects the expression of KRAS mRNA CTD PMID:17562736 pemetrexed increases response to substance ISO RGD:1350859 6480464 KRAS gene mutant form results in increased susceptibility to Pemetrexed CTD PMID:24688052 pemetrexed decreases expression ISO RGD:1350859 6480464 Pemetrexed results in decreased expression of KRAS mRNA; more ... CTD PMID:24688052 pentobarbital multiple interactions ISO RGD:1350859 6480464 Pentobarbital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of KRAS protein] CTD PMID:15263067 phlorizin decreases expression ISO RGD:1550157 6480464 Phlorhizin results in decreased expression of KRAS mRNA CTD PMID:22538082 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1350859 6480464 Methohexital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of KRAS protein]; more ... CTD PMID:15263067 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1550157 6480464 [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in increased expression of KRAS mRNA; more ... CTD PMID:16368122 picrotoxin decreases expression EXP 6480464 Picrotoxin results in decreased expression of KRAS mRNA CTD PMID:15170462 piperonyl butoxide increases mutagenesis ISO RGD:1350859 6480464 Piperonyl Butoxide results in increased mutagenesis of KRAS gene CTD PMID:7565889 pirinixic acid multiple interactions ISO RGD:1350859 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of KRAS mRNA CTD PMID:19710929 quercetin multiple interactions ISO RGD:1350859 6480464 Quercetin inhibits the reaction [KRAS protein affects the activity of TP53 protein] CTD PMID:19424582 quercetin decreases expression ISO RGD:1350859 6480464 Quercetin results in decreased expression of KRAS mRNA; more ... CTD PMID:10652438 PMID:9381980 Rebamipide increases expression EXP 6480464 rebamipide results in increased expression of KRAS mRNA CTD PMID:18299717 resveratrol decreases expression ISO RGD:1350859 6480464 resveratrol results in decreased expression of KRAS mRNA; more ... CTD PMID:12002526 more ... resveratrol decreases expression ISO RGD:1550157 6480464 resveratrol results in decreased expression of KRAS protein mutant form CTD PMID:25280562 riddelliine increases mutagenesis ISO RGD:1550157 6480464 riddelliine results in increased mutagenesis of KRAS gene CTD PMID:13678655 PMID:20737008 SB 431542 multiple interactions ISO RGD:1350859 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KRAS mRNA; more ... CTD PMID:27188386 secobarbital multiple interactions ISO RGD:1350859 6480464 Secobarbital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of KRAS protein] CTD PMID:15263067 selumetinib multiple interactions ISO RGD:1350859 6480464 AZD 6244 inhibits the reaction [[KRAS protein mutant form affects the susceptibility to vemurafenib] promotes the reaction [TNFRSF10B protein results in increased cleavage of CASP3 protein]]; more ... CTD PMID:27222248 simvastatin decreases prenylation ISO RGD:1350859 6480464 Simvastatin results in decreased prenylation of KRAS protein CTD PMID:8063617 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of KRAS mRNA CTD PMID:11241755 sodium arsenite multiple interactions ISO RGD:1550157 6480464 [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in increased expression of KRAS mRNA; more ... CTD PMID:16368122 sodium arsenite affects expression ISO RGD:1350859 6480464 sodium arsenite affects the expression of KRAS protein CTD PMID:17384772 sodium arsenite affects expression ISO RGD:1550157 6480464 sodium arsenite affects the expression of KRAS mRNA CTD PMID:16507464 sodium arsenite increases expression ISO RGD:1350859 6480464 sodium arsenite results in increased expression of KRAS protein CTD PMID:24431212 PMID:25804888 sodium arsenite increases expression ISO RGD:1550157 6480464 sodium arsenite results in increased expression of KRAS mRNA; more ... CTD PMID:16014739 PMID:16507464 Soman increases expression EXP 6480464 Soman results in increased expression of KRAS mRNA CTD PMID:19281266 styrene increases response to substance ISO RGD:1550157 6480464 KRAS gene polymorphism results in increased susceptibility to Styrene CTD PMID:12807761 sulfur dioxide increases expression EXP 6480464 Sulfur Dioxide results in increased expression of KRAS mRNA; more ... CTD PMID:19434695 sulindac affects response to substance ISO RGD:1350859 6480464 KRAS protein affects the susceptibility to Sulindac CTD PMID:11751493 tacrolimus hydrate increases expression ISO RGD:1550157 6480464 Tacrolimus results in increased expression of KRAS mRNA CTD PMID:25270620 testosterone enanthate affects expression ISO RGD:1350859 6480464 testosterone enanthate affects the expression of KRAS mRNA CTD PMID:17440010 tetrachloromethane affects expression ISO RGD:1550157 6480464 Carbon Tetrachloride affects the expression of KRAS mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of KRAS mRNA CTD PMID:8847708 Tetranitromethane increases mutagenesis ISO RGD:1550157 6480464 Tetranitromethane results in increased mutagenesis of KRAS gene CTD PMID:14713543 thiamylal multiple interactions ISO RGD:1350859 6480464 Thiamylal inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of KRAS protein] CTD PMID:15263067 thimerosal decreases expression ISO RGD:1350859 6480464 Thimerosal results in decreased expression of KRAS mRNA CTD PMID:27188386 tiazofurine multiple interactions ISO RGD:1350859 6480464 Guanosine inhibits the reaction [tiazofurin results in decreased expression of KRAS] CTD PMID:9381980 tiazofurine decreases expression ISO RGD:1350859 6480464 tiazofurin results in decreased expression of KRAS CTD PMID:9381980 tipifarnib increases expression EXP 6480464 tipifarnib results in increased expression of KRAS mRNA CTD PMID:16403772 titanium dioxide decreases expression ISO RGD:1550157 6480464 titanium dioxide results in decreased expression of KRAS mRNA CTD PMID:23557971 titanium dioxide affects expression ISO RGD:1550157 6480464 titanium dioxide affects the expression of KRAS mRNA CTD PMID:17656681 toluene affects expression EXP 6480464 Toluene affects the expression of KRAS mRNA CTD PMID:21827849 trimetrexate increases response to substance ISO RGD:1350859 6480464 KRAS gene mutant form results in increased susceptibility to Trimetrexate CTD PMID:24688052 Triptolide increases expression EXP 6480464 triptolide results in increased expression of KRAS mRNA CTD PMID:23639586 urethane affects response to substance ISO RGD:1550157 6480464 KRAS gene affects the susceptibility to Urethane CTD PMID:11807781 urethane decreases expression ISO RGD:1350859 6480464 Urethane results in decreased expression of KRAS mRNA CTD PMID:28818685 urethane increases mutagenesis ISO RGD:1550157 6480464 Urethane results in increased mutagenesis of KRAS gene CTD PMID:10779650 urethane increases mutagenesis EXP 6480464 Urethane results in increased mutagenesis of KRAS gene CTD PMID:18271921 urethane decreases expression ISO RGD:1550157 6480464 Urethane results in decreased expression of KRAS mRNA CTD PMID:16289808 ursodeoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid inhibits the reaction [Azoxymethane results in increased mutagenesis of KRAS gene] CTD PMID:12839936 valproic acid increases expression ISO RGD:1350859 6480464 Valproic Acid results in increased expression of KRAS mRNA CTD PMID:28001369 vemurafenib affects response to substance ISO RGD:1350859 6480464 KRAS protein mutant form affects the susceptibility to vemurafenib CTD PMID:27222248 vemurafenib multiple interactions ISO RGD:1350859 6480464 [KRAS protein mutant form affects the susceptibility to vemurafenib] promotes the reaction [TNFRSF10B protein results in increased cleavage of CASP3 protein]; more ... CTD PMID:27222248 vinyl carbamate multiple interactions ISO RGD:1550157 6480464 diallyl sulfone inhibits the reaction [vinyl carbamate results in increased mutagenesis of KRAS gene] CTD PMID:20205516 vinyl carbamate increases mutagenesis ISO RGD:1550157 6480464 vinyl carbamate results in increased mutagenesis of KRAS gene CTD PMID:20205516 zearalenone decreases expression ISO RGD:1550157 6480464 Zearalenone results in decreased expression of KRAS mRNA CTD PMID:30717214 zearalenone increases expression ISO RGD:1550157 6480464 Zearalenone results in increased expression of KRAS mRNA CTD PMID:29758222 zidovudine increases mutagenesis ISO RGD:1550157 6480464 Zidovudine results in increased mutagenesis of KRAS gene CTD PMID:18800350 zinc protoporphyrin multiple interactions ISO RGD:1350859 6480464 [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of KRAS mRNA CTD PMID:22839698 zoledronic acid increases expression ISO RGD:1350859 6480464 zoledronic acid results in increased expression of KRAS protein CTD PMID:28871336
Biological Process actin cytoskeleton organization ISO RGD:1550157 1624291 MGI:MGI:97306 RGD MGI:MGI:3526457 PMID:15665300 actin cytoskeleton organization IEA UniProtKB:P32883|ensembl:ENSMUSP00000032399 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 cytokine-mediated signaling pathway IMP 1600488 RGD endocrine signaling ISO RGD:1550157 1624291 RGD MGI:MGI:5607181 PMID:25133424 endocrine signaling IEA UniProtKB:P32883|ensembl:ENSMUSP00000032399 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 epithelial tube branching involved in lung morphogenesis ISO RGD:1550157 1624291 MGI:MGI:98371 RGD MGI:MGI:5523405 PMID:24058167 epithelial tube branching involved in lung morphogenesis IEA UniProtKB:P32883|ensembl:ENSMUSP00000032399 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 female pregnancy IEP 11570399 RGD forebrain astrocyte development ISO RGD:1550157 1624291 MGI:MGI:2429948 RGD MGI:MGI:5440388 PMID:22577135 forebrain astrocyte development IEA UniProtKB:P32883|ensembl:ENSMUSP00000032399 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 homeostasis of number of cells within a tissue ISO RGD:1550157 1624291 MGI:MGI:99511 RGD MGI:MGI:5588640 PMID:24675817 homeostasis of number of cells within a tissue IEA UniProtKB:P32883|ensembl:ENSMUSP00000032399 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 liver development IEP 11060153 RGD negative regulation of cell differentiation ISO RGD:1550157 1624291 RGD MGI:MGI:5523405 PMID:24058167 negative regulation of cell differentiation IEA UniProtKB:P32883|ensembl:ENSMUSP00000032399 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of neuron apoptotic process ISO RGD:1550157 1624291 MGI:MGI:96224|MGI:MGI:97306 RGD MGI:MGI:1861510 PMID:10845775 negative regulation of neuron apoptotic process IEA UniProtKB:P32883|ensembl:ENSMUSP00000032399 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of cell population proliferation ISO RGD:1350859 1624291 RGD PMID:23698361 positive regulation of cell population proliferation ISS UniProtKB:P01116 1600115 GO_REF:0000024 UniProt GO_REF:0000024 positive regulation of cell population proliferation ISO RGD:1550157 1624291 MGI:MGI:97306 RGD MGI:MGI:3526457 PMID:15665300 positive regulation of cellular senescence IMP 11060281 RGD positive regulation of gene expression ISO RGD:1350859 1624291 RGD PMID:22065586 positive regulation of gene expression IEA UniProtKB:P32883|ensembl:ENSMUSP00000032399 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of gene expression IEA UniProtKB:P01116|ensembl:ENSP00000256078 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of gene expression ISO RGD:1550157 1624291 MGI:MGI:2429948 RGD MGI:MGI:5440388 PMID:22577135 positive regulation of MAP kinase activity IMP 1600497 RGD positive regulation of NF-kappaB transcription factor activity IMP 1600488 RGD positive regulation of nitric-oxide synthase activity IMP 1600488 RGD positive regulation of protein phosphorylation ISO RGD:1350859 1624291 RGD PMID:22065586 positive regulation of Rac protein signal transduction ISO RGD:1550157 1624291 MGI:MGI:97306 RGD MGI:MGI:3526457 PMID:15665300 positive regulation of Rac protein signal transduction IEA UniProtKB:P32883|ensembl:ENSMUSP00000032399 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 Ras protein signal transduction ISO RGD:1550157 1624291 MGI:MGI:2429948|MGI:MGI:97306 RGD MGI:MGI:3526457 more ... Ras protein signal transduction IBA FB:FBgn0003205|FB:FBgn0015286|MGI:MGI:108054|MGI:MGI:1914172|MGI:MGI:96224|MGI:MGI:96680|PANTHER:PTN001529867|RGD:2827|UniProtKB:P01112|UniProtKB:Q92963|dictyBase:DDB_G0281385|dictyBase:DDB_G0293434 13792537 PMID:21873635 GO_Central regulation of long-term neuronal synaptic plasticity ISO RGD:1550157 1624291 MGI:MGI:97306 RGD MGI:MGI:2157992 PMID:11793011 regulation of long-term neuronal synaptic plasticity IEA UniProtKB:P32883|ensembl:ENSMUSP00000032399 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of protein stability ISO RGD:1350859 1624291 RGD PMID:24623306 regulation of protein stability ISS UniProtKB:P01116 1600115 GO_REF:0000024 UniProt GO_REF:0000024 regulation of synaptic transmission, GABAergic ISO RGD:1550157 1624291 MGI:MGI:97306 RGD MGI:MGI:2157992 PMID:11793011 regulation of synaptic transmission, GABAergic IEA UniProtKB:P32883|ensembl:ENSMUSP00000032399 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to glucocorticoid IEP 1581767 RGD response to glucocorticoid IEP 1581770 RGD response to isolation stress IEP 2314839 RGD response to mineralocorticoid IEP 1581767 RGD striated muscle cell differentiation ISO RGD:1550157 1624291 MGI:MGI:97874 RGD MGI:MGI:3511080 PMID:15542848 striated muscle cell differentiation IEA UniProtKB:P32883|ensembl:ENSMUSP00000032399 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 visual learning ISO RGD:1550157 1624291 MGI:MGI:97306 RGD MGI:MGI:2157992 PMID:11793011 visual learning IEA UniProtKB:P32883|ensembl:ENSMUSP00000032399 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 Cellular Component cytoplasm ISO RGD:1350859 1624291 RGD PMID:23698361 cytosol IEA UniProtKB-SubCell:SL-0091 1600115 GO_REF:0000039 UniProt GO_REF:0000039 extrinsic component of cytoplasmic side of plasma membrane ISO RGD:1350859 1624291 RGD PMID:23698361 extrinsic component of cytoplasmic side of plasma membrane ISS UniProtKB:P01116 1600115 GO_REF:0000024 UniProt GO_REF:0000024 membrane ISO RGD:1550157 1624291 MGI:MGI:1888594 RGD MGI:MGI:1333599 more ... membrane raft IDA 1581766 RGD mitochondrion IDA 2314839 RGD plasma membrane TAS 1600115 Reactome:R-NUL-9032387 Reactome Reactome:R-NUL-9032387 plasma membrane IBA FB:FBgn0003205|FB:FBgn0015286|MGI:MGI:108053|MGI:MGI:108054|MGI:MGI:97852|PANTHER:PTN000631348|PomBase:SPAC17H9.09c|RGD:2827|SGD:S000000622|SGD:S000003384|SGD:S000005042|SGD:S000005627|UniProtKB:A0A1D8PS50|UniProtKB:E9QX28|UniProtKB:O95057|UniProtKB:P01112|UniProtKB:P01116|UniProtKB:P10114|UniProtKB:P11233|UniProtKB:P11234|UniProtKB:P61225|UniProtKB:Q96HU8|UniProtKB:Q99578|UniProtKB:Q9Y3L5|dictyBase:DDB_G0281385|dictyBase:DDB_G0292998|dictyBase:DDB_G0293434 13792537 PMID:21873635 GO_Central plasma membrane TAS 1600115 Reactome:R-RNO-112378 Reactome Reactome:R-RNO-112378 plasma membrane TAS 1600115 Reactome:R-RNO-112377 Reactome Reactome:R-RNO-112377 plasma membrane TAS 1600115 Reactome:R-NUL-9616949 Reactome Reactome:R-NUL-9616949 plasma membrane TAS 1600115 Reactome:R-RNO-9030763 Reactome Reactome:R-RNO-9030763 Molecular Function GDP binding IDA 1581766 RGD GDP binding IBA PANTHER:PTN000631348|PomBase:SPAC17H9.09c|PomBase:SPBC428.16c|RGD:2981|RGD:621840|UniProtKB:P01112|UniProtKB:P10114|UniProtKB:P10301|UniProtKB:P11233|UniProtKB:P11234|UniProtKB:P61224|UniProtKB:P61225|UniProtKB:Q15382|UniProtKB:Q9Y3L5 13792537 PMID:21873635 GO_Central GMP binding IDA 1581766 RGD GTP binding IBA MGI:MGI:108053|MGI:MGI:108054|MGI:MGI:96224|MGI:MGI:97912|PANTHER:PTN000631348|PomBase:SPAC17H9.09c|PomBase:SPBC428.16c|RGD:1359694|RGD:621840|SGD:S000005042|UniProtKB:O95057|UniProtKB:P01112|UniProtKB:P10114|UniProtKB:P11233|UniProtKB:P11234|UniProtKB:P61224|UniProtKB:P61225|UniProtKB:Q15382|UniProtKB:Q8TAI7|UniProtKB:Q92963|UniProtKB:Q96HU8|UniProtKB:Q9Y3L5|WB:WBGene00002335|dictyBase:DDB_G0281385|dictyBase:DDB_G0291237|dictyBase:DDB_G0293434 13792537 PMID:21873635 GO_Central GTPase activity ISO RGD:1550157 1624291 MGI:MGI:97306 RGD MGI:MGI:3526457 PMID:15665300 GTPase activity IBA FB:FBgn0003205|FB:FBgn0004636|FB:FBgn0015286|FB:FBgn0041191|MGI:MGI:108054|MGI:MGI:1927243|MGI:MGI:96680|MGI:MGI:97852|PANTHER:PTN000631348|PomBase:SPAC17H9.09c|PomBase:SPBC428.16c|RGD:621840|SGD:S000003384|SGD:S000005042|SGD:S000005627|UniProtKB:O95057|UniProtKB:P01112|UniProtKB:P10114|UniProtKB:P10301|UniProtKB:P11234|UniProtKB:P61224|UniProtKB:Q12526|UniProtKB:Q5ANJ9|UniProtKB:Q92963|UniProtKB:Q96A58|dictyBase:DDB_G0281385|dictyBase:DDB_G0291237|dictyBase:DDB_G0293434 13792537 PMID:21873635 GO_Central identical protein binding ISO RGD:1350859 1624291 UniProtKB:P01116-2 RGD PMID:26051715 LRR domain binding IDA 1581766 RGD protein binding IPI UniProtKB:O08773 8554645 PMID:19319189 UniProt protein binding ISO RGD:1550157 1624291 UniProtKB:P04049|UniProtKB:Q01279|UniProtKB:Q80UQ2|UniProtKB:Q99N57 RGD MGI:MGI:3688344 more ... protein binding ISO RGD:1350859 1624291 UniProtKB:P04049|UniProtKB:P50749|UniProtKB:Q04631|UniProtKB:Q96II5 RGD PMID:10673434 more ... protein-containing complex binding ISO RGD:1350859 1624291 RGD PMID:23209302 protein-containing complex binding IEA UniProtKB:P01116|ensembl:ENSP00000256078 1600115 GO_REF:0000107 Ensembl GO_REF:0000107
Gene-Chemical Interaction Annotations
